Valiant Laboratories Limited (VALIANTLAB.NS)

INR 128.1

(14.76%)

EBITDA Summary of Valiant Laboratories Limited

  • Valiant Laboratories Limited's latest annual EBITDA in 2023 was 12.73 Million INR , down -96.81% from previous year.
  • Valiant Laboratories Limited's latest quarterly EBITDA in 2024 Q1 was 4.25 Million INR , up 120.99% from previous quarter.
  • Valiant Laboratories Limited reported an annual EBITDA of 399.53 Million INR in 2022, down -9.94% from previous year.
  • Valiant Laboratories Limited reported an annual EBITDA of 442.67 Million INR in 2021, down -13.71% from previous year.
  • Valiant Laboratories Limited reported a quarterly EBITDA of 15.73 Million INR for 2023 Q2, down -74.87% from previous quarter.
  • Valiant Laboratories Limited reported a quarterly EBITDA of N/A for 2023 FY, down -96.81% from previous quarter.

Annual EBITDA Chart of Valiant Laboratories Limited (2023 - 2020)

Historical Annual EBITDA of Valiant Laboratories Limited (2023 - 2020)

Year EBITDA EBITDA Growth
2023 12.73 Million INR -96.81%
2022 399.53 Million INR -9.94%
2021 442.67 Million INR -13.71%
2020 514.14 Million INR 0.0%

Peer EBITDA Comparison of Valiant Laboratories Limited

Name EBITDA EBITDA Difference
Sigachi Industries Limited 883.39 Million INR 98.558%
Ind-Swift Limited 1.06 Billion INR 98.804%
Bajaj HealthCare Limited 406.23 Million INR 96.864%
Sakar Healthcare Limited 393.26 Million INR 96.761%
Aurobindo Pharma Limited 61.78 Billion INR 99.979%
Innova Captab Limited 1.66 Billion INR 99.236%
Divi's Laboratories Limited 25.43 Billion INR 99.95%
AstraZeneca Pharma India Limited 2.35 Billion INR 99.459%
Morepen Laboratories Limited 1.72 Billion INR 99.262%
Mankind Pharma Limited 28.09 Billion INR 99.955%
Sequent Scientific Limited 549.8 Million INR 97.683%
Wanbury Limited 985.49 Million INR 98.707%
Laurus Labs Limited 8 Billion INR 99.841%
Nectar Lifesciences Limited 1.53 Billion INR 99.17%
Glenmark Life Sciences Limited 6.86 Billion INR 99.814%
Alembic Limited 1.11 Billion INR 98.859%
Hikal Limited 2.69 Billion INR 99.527%
Alembic Pharmaceuticals Limited 9.61 Billion INR 99.868%
Neuland Laboratories Limited 4.74 Billion INR 99.732%
J. B. Chemicals & Pharmaceuticals Limited 9.33 Billion INR 99.864%
Glenmark Pharmaceuticals Limited 11.34 Billion INR 99.888%
IOL Chemicals and Pharmaceuticals Limited 2.6 Billion INR 99.511%
Themis Medicare Limited 562.6 Million INR 97.736%
RPG Life Sciences Limited 1.28 Billion INR 99.006%
Zydus Lifesciences Limited 56.22 Billion INR 99.977%
Lupin Limited 36.96 Billion INR 99.966%
Amrutanjan Health Care Limited 681.59 Million INR 98.131%
Wockhardt Limited 1.08 Billion INR 98.82%
Vaishali Pharma Limited 31.71 Million INR 59.828%
Aarti Pharmalabs Limited 3.9 Billion INR 99.674%
Jagsonpal Pharmaceuticals Limited 323.46 Million INR 96.062%
Jubilant Pharmova Limited 8 Billion INR 99.841%
FDC Limited 3.38 Billion INR 99.624%
Dr. Reddy's Laboratories Limited 88.27 Billion INR 99.986%
Kilitch Drugs (India) Limited 287.42 Million INR 95.568%
Eris Lifesciences Limited 6.98 Billion INR 99.818%
Venus Remedies Limited 711.8 Million INR 98.21%
ZIM Laboratories Limited 462.09 Million INR 97.243%
Bliss GVS Pharma Limited 1.47 Billion INR 99.139%
Par Drugs and Chemicals Limited 228.17 Million INR 94.417%
Caplin Point Laboratories Limited 6.18 Billion INR 99.794%
Shilpa Medicare Limited 2.58 Billion INR 99.508%
Albert David Limited 1.04 Billion INR 98.781%
Ajanta Pharma Limited 12.56 Billion INR 99.899%
Hester Biosciences Limited 539.47 Million INR 97.639%
Suven Pharmaceuticals Limited 4.67 Billion INR 99.728%
Solara Active Pharma Sciences Limited -2.82 Billion INR 100.451%
Gufic Biosciences Limited 1.48 Billion INR 99.14%
Windlas Biotech Limited 781.72 Million INR 98.37%
Procter & Gamble Health Limited 3.07 Billion INR 99.586%
Aarey Drugs & Pharmaceuticals Limited 45.16 Million INR 71.795%
Mangalam Drugs & Organics Limited 174.94 Million INR 92.718%
Granules India Limited 8.6 Billion INR 99.852%
Aarti Drugs Limited 3.24 Billion INR 99.608%
Bal Pharma Limited 345.59 Million INR 96.314%
Alkem Laboratories Limited 24.19 Billion INR 99.947%
Sun Pharmaceutical Industries Limited 138.36 Billion INR 99.991%
Lincoln Pharmaceuticals Limited 1.34 Billion INR 99.052%
Medicamen Biotech Limited 245.66 Million INR 94.814%
Unichem Laboratories Limited 742.35 Million INR 98.284%
Bafna Pharmaceuticals Limited 114.58 Million INR 88.882%
Biofil Chemicals and Pharmaceuticals Limited 12.99 Million INR 1.978%
Orchid Pharma Limited 1.41 Billion INR 99.102%
Medico Remedies Limited 129.09 Million INR 90.132%
Ind-Swift Laboratories Limited 6.86 Billion INR 99.814%
Ipca Laboratories Limited 13.29 Billion INR 99.904%
Brooks Laboratories Limited 41.72 Million INR 69.471%
Syncom Formulations (India) Limited 430.27 Million INR 97.039%
Piramal Enterprises Limited -3.86 Billion INR 100.33%
Torrent Pharmaceuticals Limited 35 Billion INR 99.964%
NATCO Pharma Limited 18.79 Billion INR 99.932%
Suven Life Sciences Limited -992.78 Million INR 101.283%
Krebs Biochemicals & Industries Limited -82.72 Million INR 115.399%
Strides Pharma Science Limited 3.76 Billion INR 99.662%
Indoco Remedies Limited 2.64 Billion INR 99.519%
Alpa Laboratories Limited 229.96 Million INR 94.46%
Lasa Supergenerics Limited -65.08 Million INR 119.574%
Sun Pharma Advanced Research Company Limited -3.73 Billion INR 100.341%